Live Breaking News & Updates on Tricuspid Device Clinical Trial Overview

Stay updated with breaking news from Tricuspid device clinical trial overview. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Abbott Receives CE Mark and Canadian Approval for Next-Generation TriClip Tricuspid Valve Repair Device


Abbott Receives CE Mark and Canadian Approval for Next-Generation TriClip Tricuspid Valve Repair Device
New enhancements to first-of-its-kind device uniquely developed for the difficult-to-treat tricuspid valve
The new generation Abbott TriClip G4 device has gained European and Canadian approvals for transcatheter tricuspid valve repair (TTVR). The device is an iteration of the successful MitraClip device used for transcatheter mitral valve repairs. 
April 8, 2021 Abbott today announced it has received European CE mark and Health Canada authorization this week for its next-generation TriClip Transcatheter Tricuspid Valve Repair (TTVR) System, a minimally invasive tricuspid heart valve repair device to treat tricuspid regurgitation (TR). The clip-based therapy, known as TriClip G4, is a non-surgical heart valve repair option specifically designed for the treatment of TR that allows physicians to tailor repair of the valve to each patient s unique anatomy. ....

Rebecca Hahn , Mike Dale , Philipp Lurz , Abbott Triclip , University Of Leipzig , Heart Center Leipzig , Health Canada , Triclip Transcatheter Tricuspid Valve Repair , Tricuspid Valve Repair Systems , Investigational Device Exemption , Transcatheter Tricuspid Valve Repair Content , Tricuspid Valve Imaging , Interventions Developing Hand In , Tricuspid Device Clinical Trial Overview , Ori Ben Yehuda , ரிபேக்க ஹான் , மைக் டேல் , பல்கலைக்கழகம் ஆஃப் லெயிஸீக் , இதயம் மையம் லெயிஸீக் , ஆரோக்கியம் கனடா , தலையீடுகள் வளரும் கை இல் , ஓரி பென் யேஹுதா ,